ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.52
-0.17%
US Tech 100
17,582.00
-0.17%
S&P 500
5,187.67
0.00%
US Dollar vs CAD
1.37254
-0.02%
Bitcoin
61,637.93
0.74%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. ADC Therapeutics SA (ADCT)

  7. ADC Therapeutics SA (ADCT) News

ADCT

ADC Therapeutics (ADCT)

ADC Therapeutics SA
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ADCT
DateTimeSourceHeadlineSymbolCompany
05/08/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
05/07/20243:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ADCTADC Therapeutics SA
05/07/20243:02PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ADCTADC Therapeutics SA
05/06/20246:30AMGlobeNewswire Inc.ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded WarrantsNYSE:ADCTADC Therapeutics SA
05/06/20245:51AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ADCTADC Therapeutics SA
05/06/20245:38AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ADCTADC Therapeutics SA
05/06/20245:29AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
05/06/20245:10AMGlobeNewswire Inc.ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNYSE:ADCTADC Therapeutics SA
05/06/20245:00AMGlobeNewswire Inc.ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone LymphomaNYSE:ADCTADC Therapeutics SA
05/01/20243:05PMGlobeNewswire Inc.ADC Therapeutics Makes Grants to New Employees Under Inducement PlanNYSE:ADCTADC Therapeutics SA
05/01/20246:00AMGlobeNewswire Inc.ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024NYSE:ADCTADC Therapeutics SA
04/04/20246:00AMGlobeNewswire Inc.ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin LymphomaNYSE:ADCTADC Therapeutics SA
04/03/20246:00AMGlobeNewswire Inc.ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024NYSE:ADCTADC Therapeutics SA
04/01/20243:05PMGlobeNewswire Inc.ADC Therapeutics Makes Grants to New Employees Under Inducement PlanNYSE:ADCTADC Therapeutics SA
03/13/20246:03AMIH Market NewsMixed Futures Amidst Quiet Economic Schedule; Oil Prices ClimbNYSE:ADCTADC Therapeutics SA
03/13/20246:00AMGlobeNewswire Inc.ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNYSE:ADCTADC Therapeutics SA
03/06/20246:15AMGlobeNewswire Inc.ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes SummitNYSE:ADCTADC Therapeutics SA
03/06/20246:00AMGlobeNewswire Inc.ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024NYSE:ADCTADC Therapeutics SA
03/05/20244:45PMGlobeNewswire Inc.ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual MeetingNYSE:ADCTADC Therapeutics SA
03/05/20248:15AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
02/29/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
02/27/20246:00AMGlobeNewswire Inc.ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care ConferenceNYSE:ADCTADC Therapeutics SA
01/24/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
01/19/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
01/04/20246:15AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
01/04/20246:15AMGlobeNewswire Inc.ADC Therapeutics Regains Compliance with NYSE Continued Listing StandardsNYSE:ADCTADC Therapeutics SA
01/04/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
01/04/20246:00AMGlobeNewswire Inc.ADC Therapeutics Provides Business UpdatesNYSE:ADCTADC Therapeutics SA
01/02/20247:10PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:ADCTADC Therapeutics SA
01/02/20247:05PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:ADCTADC Therapeutics SA
 Showing the most relevant articles for your search:NYSE:ADCT

Your Recent History

USOTC
BMXI
Brookmount Explorations (PK)
USOTC
RONN
Ronn Motor (PK)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
KGKG
Kona Gold Beverage (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
FLES
Auto Parts 4Less (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
ILST
International Star (PK)
NASDAQ
PLUG
Plug Power
USOTC
IBGR
Nexus Energy Services (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
TKMO
Tekumo (PK)
USOTC
CEOS
CeCors (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved